Product Description
BELLAST® SOFT L Product Overview
BELLAST® SOFT L is a hyaluronic acid (HA) dermal filler tailored for treating fine wrinkles and delicate facial lines, including crow’s feet and perioral wrinkles. Formulated with cross-linked hyaluronic acid and 3 mg of lidocaine to minimize discomfort, BELLAST® SOFT L is intended for areas requiring subtle volume and precision. Leveraging High Concentration Cross-Linking (HCXL) Technology, this filler achieves ideal viscosity and stability for sensitive skin areas, allowing for a natural, smooth appearance.
Key Features:
- Hyaluronic Acid Concentration: 18 mg of cross-linked HA
- Lidocaine Content: 3 mg of lidocaine for comfort
- Technology: HCXL cross-linking for enhanced stability and biocompatibility
- Packaging: 1.0 ml syringe, sterile, single-use
BELLAST® SOFT L Indications for Use
BELLAST® SOFT L is designed for fine line correction and subtle volume enhancement. Its soft consistency and lower HA concentration make it ideal for areas with delicate skin, providing natural-looking results in the superficial to mid-dermis.
Primary Indications:
- Crow’s Feet: Smooths fine lines around the eyes.
- Perioral Lines: Reduces fine lines around the mouth.
- Superficial Wrinkles: Treats subtle facial lines and improves hydration.
- Lip Line Definition: Enhances lip contour without adding excessive volume.
BELLAST® SOFT L Dosage Information
Administered using careful injection techniques, BELLAST® SOFT L is designed to achieve fine line smoothing without overcorrection.
Treatment Protocols:
- Injection Volume: 1 ml per session, adjustable based on the area and patient needs.
- Injection Depth: Superficial to mid-dermis for subtle volume restoration.
- Frequency of Treatment: Generally requires one session, with touch-ups every 6-9 months depending on individual preferences and needs.
BELLAST® SOFT L Side Effects and Precautions
BELLAST® SOFT L is well-tolerated, with mild, temporary side effects due to its gentle formulation. The inclusion of lidocaine minimizes injection discomfort.
Common Side Effects:
- Redness and Swelling: Temporary at the injection site, resolving within 1-2 days.
- Bruising: Minor bruising may occur, particularly in sensitive areas.
- Tenderness: Mild tenderness is common but subsides shortly after treatment.
Precautions:
- Aseptic Technique: Essential to prevent infections.
- Contraindications: Avoid in patients with autoimmune diseases, allergies to HA or lidocaine, or active infections.
- Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding.
- Post-Treatment Care: Patients should avoid strenuous physical activity and sun exposure for at least 24 hours following treatment.
BELLAST® SOFT L Clinical Studies or Real-World Outcomes
BELLAST® SOFT L has shown significant results in fine line reduction and superficial wrinkle smoothing with high patient satisfaction due to its natural appearance and effective wrinkle reduction.
Key Findings:
- Fine Line Reduction: Patients observed 30-40% improvement in fine line depth post-treatment.
- Natural Volume Restoration: Creates smoother skin without a heavy or artificial appearance.
- Patient Satisfaction: High satisfaction rates due to comfortable injection and effective fine line reduction, with 92% satisfaction at follow-up visits.
Clinical Observations:
- Durability: Effects typically last between 6 to 9 months, particularly around the eyes and mouth.
- Minimal Adverse Effects: The HCXL technology enhances safety and stability, making BELLAST® SOFT L suitable for sensitive areas without significant adverse effects.
BELLAST® SOFT L Composition and Active Ingredients
BELLAST® SOFT L is composed of 18 mg/ml cross-linked hyaluronic acid and 3 mg lidocaine hydrochloride for painless and effective treatment.
Key Ingredients:
- Cross-Linked Hyaluronic Acid (18 mg/ml): Supports skin hydration, smooths fine lines, and improves elasticity.
- Lidocaine (3 mg): Provides pain relief, enhancing comfort during and after treatment.
- HCXL Technology: Creates a stable, biocompatible HA gel, minimizing potential migration and ensuring natural results.
BELLAST® SOFT L Drug Interactions
BELLAST® SOFT L is a localized filler with minimal systemic effects, which lowers the risk of drug interactions.
Important Considerations:
- Combination with Other Treatments: Can be combined with other fillers or biostimulation treatments, though a two-week interval is advised between procedures.
- Anticoagulants: Patients on blood thinners should be informed of the increased likelihood of bruising.
- Immunosuppressive Therapy: Use cautiously with immunosuppressive treatments, as patients may be more prone to infection.
